Service d'Anesthésie Réanimation 1, Hôpital Pellegrin, CHU de Bordeaux, France.
J Neurotrauma. 2011 Oct;28(10):2003-12. doi: 10.1089/neu.2011.1929. Epub 2011 Sep 23.
The potential superiority of hypertonic saline (HTS) over mannitol (MTL) for control of intracranial pressure (ICP) following traumatic brain injury (TBI) is still debated. Forty-seven severe TBI patients with increased ICP were prospectively recruited in two university hospitals and randomly treated with equiosmolar infusions of either MTL 20% (4 mL/kg; n=25 patients) or HTS 7.5% (2 mL/kg; n=22 patients). Serum sodium, hematocrit, ICP, arterial blood pressure, cerebral perfusion pressure (CPP), shear rate, global indices of cerebral blood flow (CBF) and metabolism were measured before, and 30 and 120 min following each infusion during the course of illness. Outcome was assessed at 6 months. Both HTS and MTL effectively and equally reduced ICP levels with subsequent elevation of CPP and CBF, although this effect was significantly stronger and of longer duration after HTS and correlated with improved rheological blood properties induced by HTS. Further, effect of HTS on ICP appeared to be more robust in patients with diffuse brain injury. In contrast, oxygen and glucose metabolic rates were left equally unaffected by both solutions. Accordingly, there was no significant difference in neurological outcome between the two groups. In conclusion, MTL was as effective as HTS in decreasing ICP in TBI patients although both solutions failed to improved cerebral metabolism. HTS showed an additional and stronger effect on cerebral perfusion of potential benefit in the presence of cerebral ischemia. Treatment selection should therefore be individually based on sodium level and cerebral hemodynamics.
高渗盐水(HTS)在控制创伤性脑损伤(TBI)后颅内压(ICP)方面优于甘露醇(MTL)的潜在优势仍存在争议。两所大学医院前瞻性地招募了 47 名 ICP 升高的严重 TBI 患者,并随机接受等渗 MTL 20%(4 mL/kg;n=25 例患者)或 HTS 7.5%(2 mL/kg;n=22 例患者)治疗。在发病过程中,分别在每次输注前、输注后 30 和 120 分钟测量血清钠、红细胞压积、ICP、动脉血压、脑灌注压(CPP)、剪切率、脑血流(CBF)和代谢的全局指数。在 6 个月时评估结果。HTS 和 MTL 均能有效且同等地降低 ICP 水平,随后 CPP 和 CBF 升高,尽管 HTS 的作用更强、持续时间更长,并且与 HTS 诱导的血液流变学特性改善相关。此外,HTS 对弥漫性脑损伤患者的 ICP 影响似乎更强。相比之下,两种溶液对氧和葡萄糖代谢率的影响没有差异。因此,两组之间的神经结局没有显著差异。总之,MTL 在降低 TBI 患者 ICP 方面与 HTS 同样有效,尽管两种溶液都未能改善脑代谢。HTS 对脑灌注有额外的、更强的作用,在存在脑缺血的情况下可能有益。因此,治疗选择应根据钠水平和脑血流动力学单独进行。